Comment on: Exploring the association between weight loss-inducing medications and multiple sclerosis: insights from the FDA adverse event reporting system database
Idioma
EN
Article de revue
Este ítem está publicado en
Therapeutic Advances in Neurological Disorders. 2024-09-12, vol. 17, p. 1-2
Palabras clave en inglés
Disproportionality Analysis
Drug Repurposing
Pharmacovigilance
Centros de investigación